Revance Therapeutics Announces Proposed Public Offering of Common Stock

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. NVDA
2. BAC
3. DPZ
4. GS
5. UNH
6. ORCL
7. DRS
8. JPM
9. ACI
10. CRWV

Go back to Revance Therapeutics Announces Proposed Public Offering of Common Stock

Revance Therapeutics (RVNC) Prices 3.25M Common Offering at $36/Share

November 4, 2015 7:08 AM EST

Revance Therapeutics (NASDAQ: RVNC) announced the pricing of its underwritten public offering of 3,250,000 shares of its common stock at a price to the public of $36.00 per share. Revance also granted the underwriters a 30-day option to acquire an additional 487,500 shares from Revance. The offering... More

Revance Therapeutics (RVNC) Announces 3.25M Stock Offering

November 2, 2015 6:25 AM EST

Revance Therapeutics (NASDAQ: RVNC) announced a proposed underwritten public offering of 3,250,000 shares of its common stock. Revance expects to grant the underwriters a 30-day option to acquire an additional 487,500shares. The offering is subject to market and other conditions, and there... More